Extrawell Pharmaceutical Holdings financials at a glance

Year Year 2005 2006 2007 2008 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2009 2022 2023 2024 2025
Rev. Revenue
HK$169.77M HK$178.27M HK$158.76M HK$165.08M HK$196.29M HK$198.82M HK$157.41M HK$151.07M HK$150.67M HK$128.83M HK$142.20M HK$107.90M HK$85.76M HK$89.22M HK$77.58M HK$78.80M HK$184.43M HK$73.93M HK$72.58M HK$0.00M HK$0.00M
GM % Gross Margin %
27.15% 39.16% 30.72% 31.55% 27.43% 26.17% 30.15% 30.91% 49.09% 39.63% 48.74% 40.68% 49.03% 55.59% 55.32% 54.02% 31.39% 50.80% 42.91% 0.00% 0.00%
OM Operating Margin
0.55% 13.18% 4.77% 0.80% 6.16% 2.04% 3.13% 6.79% -1.87% -10.00% 0.34% -13.91% -20.08% -19.02% -10.42% -13.79% 3.18% -17.51% -15.54% 0.00% 0.00%
EPS Earnings Per Share
HK$0.04 HK$0.00
Div. Dividends
HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00 HK$0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
2,290m 2,290m 2,290m 2,290m 2,290m 2,290m 2,290m 2,290m 2,390m 2,390m 2,390m 2,390m 2,390m 2,390m 2,390m 2,390m 0m 2,390m 2,390m 2,390m 0m
OCF Operating Cash Flow
HK$25.59M HK$16.75M HK$10.11M HK$4.35M HK$31.37M HK$18.67M HK$9.48M HK$10.41M HK$64.11M HK$-23.49M HK$6.27M HK$5.48M HK$-4.88M HK$-15.09M HK$-13.25M HK$-0.85M HK$2.20M HK$-1.77M HK$1.18M HK$0.00M HK$0.00M
FCF Free Cash Flow
HK$24.62M HK$15.59M HK$9.52M HK$4.06M HK$29.95M HK$17.60M HK$6.74M HK$-30.91M HK$-75.16M HK$-28.09M HK$5.79M HK$4.47M HK$-5.00M HK$-16.50M HK$-13.41M HK$-1.57M HK$-1.12M HK$-11.40M HK$-5.44M HK$0.00M HK$0.00M
FCFS Free Cash Flow Per Share
HK$0.01 HK$0.01 HK$0.00 HK$0.00 HK$0.01 HK$0.01 HK$0.00 HK$-0.01 HK$-0.03 HK$-0.01 HK$0.00 HK$0.00 HK$-0.00 HK$-0.01 HK$-0.01 HK$-0.00 HK$-0.00 HK$-0.00 HK$-0.00 HK$0.00 HK$0.00